Literature DB >> 24251678

Deep intronic KRIT1 mutation in a family with clinically silent multiple cerebral cavernous malformations.

F Riant1, S Odent, M Cecillon, L Pasquier, C de Baracé, M P Carney, E Tournier-Lasserve.   

Abstract

Loss-of-function mutations in CCM1/KRIT1, CCM2/MGC4607 and CCM3/PDCD10 genes are identified in the vast majority of familial cases with multiple cerebral cavernous malformations (CCMs). However, genomic DNA sequencing combined to large rearrangement screening fails to detect a mutation in 5% of those cases. We report a family in which CCM lesions were discovered fortuitously because of the investigation of a developmental delay in a boy. Three members of the family on three generations had typical multiple CCM lesions and no clinical signs related to CCM. No mutation was detected using genomic DNA sequencing and quantitative multiplex PCR of short fluorescent fragments (QMPSF). cDNA sequencing showed a 99-nucleotide insertion between exons 5 and 6 of CCM1, resulting from a mutation located deep into intron 5 (c.262+132_262+133del) that activates a cryptic splice site. This pseudoexon leads to a premature stop codon. These data highly suggest that deep intronic mutations explain part of the incomplete mutation detection rate in CCM patients and underline the importance of analyzing the cDNA to provide comprehensive CCM diagnostic tests. This kind of mutation may be responsible for apparent sporadic presentations due to a reduced penetrance.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CCM; KRIT1; cerebral cavernous malformations; deep intronic mutation

Mesh:

Substances:

Year:  2013        PMID: 24251678     DOI: 10.1111/cge.12322

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  7 in total

Review 1.  Genetics of cerebral cavernous malformations: current status and future prospects.

Authors:  H Choquet; L Pawlikowska; M T Lawton; H Kim
Journal:  J Neurosurg Sci       Date:  2015-04-22       Impact factor: 2.279

Review 2.  Cerebral Cavernous Malformations: An Update on Prevalence, Molecular Genetic Analyses, and Genetic Counselling.

Authors:  Stefanie Spiegler; Matthias Rath; Christin Paperlein; Ute Felbor
Journal:  Mol Syndromol       Date:  2018-01-25

Review 3.  Genetics of brain arteriovenous malformations and cerebral cavernous malformations.

Authors:  Hiroki Hongo; Satoru Miyawaki; Yu Teranishi; Daiichiro Ishigami; Kenta Ohara; Yu Sakai; Daisuke Shimada; Motoyuki Umekawa; Satoshi Koizumi; Hideaki Ono; Hirofumi Nakatomi; Nobuhito Saito
Journal:  J Hum Genet       Date:  2022-07-13       Impact factor: 3.755

4.  Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia.

Authors:  Masahiko Ajiro; Tomonari Awaya; Young Jin Kim; Kei Iida; Masatsugu Denawa; Nobuo Tanaka; Ryo Kurosawa; Shingo Matsushima; Saiko Shibata; Tetsunori Sakamoto; Lorenz Studer; Adrian R Krainer; Masatoshi Hagiwara
Journal:  Nat Commun       Date:  2021-07-23       Impact factor: 17.694

5.  Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.

Authors:  Niall P Keegan; Steve D Wilton; Sue Fletcher
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.772

6.  Endoscopic management of Atypical sellar cavernous hemangioma: A case report and review of the literature.

Authors:  A M Al-Sharydah; S S Al-Suhibani; S A Al-Jubran; A H Al-Abdulwahhab; M Al-Bar; H M Al-Jehani; W M Al-Issawi
Journal:  Int J Surg Case Rep       Date:  2017-12-08

7.  First interchromosomal insertion in a patient with cerebral and spinal cavernous malformations.

Authors:  Robin A Pilz; Konrad Schwefel; Anja Weise; Thomas Liehr; Philipp Demmer; Andreas Spuler; Stefanie Spiegler; Eberhard Gilberg; Christian A Hübner; Ute Felbor; Matthias Rath
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.